Critical Illness Design - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

Critical Illness Design

Description:

Male Non-Smoker issue age 20, ultimate ... Price with Cash Surrender Values (CSV) Offer Return of Premiums (ROP) Protect the Downfalls ... – PowerPoint PPT presentation

Number of Views:115
Avg rating:3.0/5.0
Slides: 37
Provided by: SYG
Category:

less

Transcript and Presenter's Notes

Title: Critical Illness Design


1
Critical IllnessDesign Pricing
Caribbean Actuarial Association- 2004 -
Accepting New Realities
Presentation by Sylvain Goulet, FCIA, FSA, MAAA
2
Critical Illness- Design Pricing -
  • Product Design Issues
  • Product Pricing Issues
  • Profitability and Risk Considerations
  • Reinsurance Issues
  • Incidence Rates Development of Rates
  • Conclusions

3
Critical Illness - Design Pricing -
  • Product Design Issues
  • Product Pricing Issues
  • Profitability and Risk Considerations
  • Reinsurance Issues
  • Incidence Rates Development of Rates
  • Conclusions

4
Product Design Issues- The Simplest Form -
  • Lump Sum Payment
  • Lump sum payment at the onset of a covered
    illness or condition
  • Not disability income
  • No proof of need required, just proof of the
    condition
  • Type
  • Stand-alone basis
  • Rider, attached to a base life insurance policy

5
Product Design Issues- The Simplest Form -
  • Major Conditions The Big 4
  • Cancer numerous alternatives
  • Heart Attack
  • Stroke
  • Coronary Artery
  • Bypass Surgery

With or without a 30-day survival period
6
Product Design Issues- The Simplest Form -
  • Other Adult Conditions
  • Alzheimer
  • Kidney failure
  • Major organ transplant
  • Paralysis, etc.
  • Children Conditions
  • Cerebral palsy
  • Cystic fibrosis
  • Downs syndrome

7
Critical Illness - Design Pricing -
  • Product Design Issues
  • Product Pricing Issues
  • Profitability and Risk Considerations
  • Reinsurance Issues
  • Incidence Rates Development of Rates
  • Conclusions

8
Product Pricing Issues- Costs Consideration -
  • Differences by Sex
  • Male incidence rates almost always higher than
    female incidence rates
  • Differences by Smoking Status
  • A big increase around ages 60-75
  • Slowdown (non-smoker) and plateau or decrease
    (smoker) around ages 80-90
  • Then rates increase very fast at older ages

9
Product Pricing Issues- Costs Consideration -
Male vs Female Non-Smoker
Prostate Cancer, Heart Attack Stroke
Breast Cancer, Heart Attack Stroke
10
Product Pricing Issues- Costs Consideration -
Male vs Female Smoker
Lung Cancer, More Severe Heart Attack Stroke
11
Product Pricing Issues- Costs Consideration -
Non-Smoker vs Smoker (Male)
Lung Cancer, More Severe Heart Attack Stroke
12
Product Pricing Issues- CI Compared to Mortality
-
  • Male Non-Smoker issue age 20, ultimate
  • Morbidity almost always higher than mortality,
    but not so at the much older ages
  • 20-29 -12
  • 30-39 33
  • 40-49 94
  • 50-59 87
  • 60-69 63
  • 70-79 14
  • 80-89 -42
  • 90-99 -64

13
Product Pricing Issues- Costs Consideration -
CI Incidence vs Mortality (Male NS)
14
Product Pricing Issues- Characteristics -
  • Much Like Life Product
  • Low incidence rates at younger ages, increasing
    rapidly at older ages
  • Smokers higher than non-smokers (lung cancer,
    heart diseases, etc.)
  • Male rates higher than female rates
  • Lapse-Supported
  • Behaves like a Term to 100
  • Must assume low lapse rates at higher durations
    and higher attained ages

15
Critical Illness - Design Pricing -
  • Product Design Issues
  • Product Pricing Issues
  • Profitability and Risk Considerations
  • Reinsurance Issues
  • Incidence Rates Development of Rates
  • Conclusions

16
Profitability and Risk Considerations- How to
Mitigate Costs -
  • Conditions Covered
  • Include the big 4 as a base plan (75-85 of
    the cost)
  • Offer other conditions as riders
  • Offer packages to avoid anti-selection
  • Differences by Smoking Status
  • Most conditions create higher rates for smoker
    than for non-smoker
  • A big increase for smokers around ages 60-75

17
Profitability and Risk Considerations - How to
Mitigate Costs -
  • Offer Other Benefits to Even Out the Costs
  • Price with Cash Surrender Values (CSV)
  • Offer Return of Premiums (ROP)
  • Protect the Downfalls
  • Offer non-guaranteed rates plus a rider for
    guaranteed rates
  • e.g. 8.00/1000 2.50/1000 for guaranteed rates
  • price the base appropriately and the rider
    conservatively

18
Profitability and Risk Considerations - How to
Mitigate Costs -
  • Change the Benefits Structure
  • Change the of benefits paid, for example
  • 20-65 100
  • grading to 70 at 75
  • grading to 60 at 80
  • grading to 45 at 90
  • grading to 25 at 100
  • Lower ultimate costs at older ages
  • Consistent with reduced financial needs (children
    gone, house paid, etc.)

19
Product Pricing Issues- Costs Consideration -
100 CI Incidence Full Benefits
20
Product Pricing Issues- Costs Consideration -
100 CI Incidence Partial Benefits
21
Profitability and Risk Considerations - How to
Mitigate Costs -
  • Change the Benefits Structure
  • Change the of benefits paid, for example
  • 20-65 100
  • grading to 70 at 75
  • grading to 60 at 80
  • grading to 45 at 90
  • grading to 25 at 100
  • Lower total premium rates for all issue ages,
    especially older ones
  • Greatly reduces the lapse-supported nature of
    these products

22
Profitability and Risk Considerations - How to
Mitigate Costs -
  • Offer RC Term Premiums
  • For example, T10 RC
  • Lower going-in premiums, increasing rapidly at
    renewal
  • Guaranteed premiums for the first 10 or 20 years,
    then non-guaranteed
  • Could increase say to age 70, then convertible to
    whole life rates
  • In Canada
  • 40 RC, 39 Level, 18 Permanent, 3 Others
    (source Munich Re Survey)

23
Profitability and Risk Considerations - How to
Mitigate Costs -
  • Differences by Country
  • Extending some countries experience to other
    countries must be done carefully
  • Focus on common characteristics
  • The Big 4 account for 75-80 (may not always be
    the case in all countries)
  • Cancers, Heart Attacks, Strokes usually well
    documented
  • Similar pattern by sex and age
  • Allow for more margins, or non-guaranteed rates

24
Critical Illness - Design Pricing -
  • Product Design Issues
  • Product Pricing Issues
  • Profitability and Risk Considerations
  • Reinsurance Issues
  • Incidence Rates Development of Rates
  • Conclusions

25
Reinsurance Issues- Typical Reinsurance
Constraints -
  • Non-Guaranteed Rates
  • Offer non-guaranteed products backed by the
    reinsurer and a Guarantee rider at a
    conservative cost (25 to 30)
  • Until the reinsurer increases the rate, you keep
    the rider premium
  • Try to negotiate maximum reinsurance rates first
    (cost of the rider)

26
Reinsurance Issues- Typical Reinsurance
Constraints -
  • Attained Age Limit (Coverage) of 65-75
  • Offer a to age 65/75 product with an
    Extension rider for life, with decreasing
    benefits after 65/75
  • Offer CSV benefits or ROP to mitigate the cost
    (not reinsured)
  • Negotiate steps down ceding percentages up front,
    maybe linked with declining benefits
  • e.g. 60 reinsured up to 75, declining to 30
    afterwards

27
Reinsurance Issues- Typical Reinsurance
Constraints -
  • Lower Face Amounts
  • Typically lower face amounts
  • Not as much need for reinsurance, depending on
    individual retention limits
  • Cost per 1000 usually more expensive

28
Critical Illness - Design Pricing -
  • Product Design Issues
  • Product Pricing Issues
  • Profitability and Risk Considerations
  • Reinsurance Issues
  • Incidence Rates Development of Rates
  • Conclusions

29
Incidence Rates- Development of Rates -
  • Empirical data
  • Difficult to obtain because limited access and
    experience (direct writers and reinsurers)
  • Research Development
  • Available in Canada, USA, UK, Australia
  • Canada much ahead of the USA, which is new at
    offering CI
  • May Need adjustment for the Caribbean, Latin
    America and other territories

30
Incidence Rates - Development of Rates -
  • See Sample Pricing Tables

31
Incidence Rates - Development of Rates -
32
Critical Illness - Design Pricing -
  • Product Design Issues
  • Product Pricing Issues
  • Profitability and Risk Considerations
  • Reinsurance Issues
  • Incidence Rates Development of Rates
  • Conclusions

33
Conclusions
  • Simple Approach
  • Big 4 causes 75-80 of total incidence
  • Incidence rates available from reinsurers (with
    exclusivity confidentiality) or consultants, no
    CSV, discount rates, etc.
  • Easy to design and price it seems so!

34
Conclusions
  • Pitfalls
  • Differences across countries lack of reliable
    or available data in many Caribbean countries
  • Differences across countries CI rates
    differences not the same as mortality rates
    differences
  • Higher profitability targets to recognize more
    uncertainty in future experience
  • Lapse-supported nature lapse rates assumption
    is crucial
  • Reinsurance restrictions work around them by
    offering special riders

35
Conclusions
  • Complex / Flexible Approach
  • Sometime large differences by sex, age, smoking
    status
  • Reflect different benefits (non-level)
  • Reflect guarantees and/or non-guarantees
  • Reflect different structure permanent, limited
    ages, RC
  • Creativity in designing a product that works for
    the markets

36
Thank you very much ...
  • If you wish a copy of this presentation, please
    send an email to syg_at_eckler.ca / website
    www.eckler.ca
Write a Comment
User Comments (0)
About PowerShow.com